4/A//SEC Filing
HINSON JOHN R 4/A
Accession 0001209191-09-011486
CIK 0001323115other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 2:19 PM ET
Size
12.2 KB
Accession
0001209191-09-011486
Insider Transaction Report
Form 4/AAmended
HINSON JOHN R
DirectorPresident & CEO
Transactions
- Sale
Common Stock
2009-01-05$7.56/sh−4,039$30,548→ 0 total - Exercise/Conversion
Common Stock
2009-01-05$2.85/sh+4,039$11,511→ 4,039 total - Exercise/Conversion
Stock Option
2009-01-05−4,039→ 159,319 totalExercise: $2.85From: 2000-08-14Exp: 2010-08-14→ Common Stock (4,039 underlying)
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person
- [F2]This price in Column 4 is a weighted average sale price. The prices actually paid ranged from $7.50 to $7.68. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Documents
Issuer
Cardiac Science CORP
CIK 0001323115
Entity typeother
Related Parties
1- filerCIK 0001228334
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 2:19 PM ET
- Size
- 12.2 KB